|
May 12
|
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
|
|
May 8
|
Just Say No to Drugs: 3 Pharma Stocks to Avoid
|
|
May 7
|
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May
|
|
May 6
|
Exelixis (EXEL) International Revenue Performance Explored
|
|
May 2
|
Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript
|
|
May 2
|
Exelixis, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
|
|
May 1
|
Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
|
|
May 1
|
Q1 2024 Exelixis Inc Earnings Call
|
|
May 1
|
Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
|
|
May 1
|
Exelixis (EXEL) Q1 2024 Earnings Call Transcript
|
|
Apr 30
|
Exelixis (EXEL) Reports Q1 Earnings: What Key Metrics Have to Say
|
|
Apr 30
|
Exelixis Inc (EXEL) Q1 2024 Earnings: Mixed Results Amidst Restructuring Efforts
|
|
Apr 30
|
Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update
|
|
Apr 27
|
The Top 3 Biotech Stocks to Buy in April 2024
|
|
Apr 26
|
Analysts Estimate Immunome, Inc. (IMNM) to Report a Decline in Earnings: What to Look Out for
|
|
Apr 26
|
Merus (MRUS) Moves 7.1% Higher: Will This Strength Last?
|
|
Apr 17
|
Institutional investors in Exelixis, Inc. (NASDAQ:EXEL) lost 3.8% last week but have reaped the benefits of longer-term growth
|
|
Apr 16
|
Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024
|
|
Apr 9
|
EXEL or REGN: Which Is the Better Value Stock Right Now?
|
|
Mar 28
|
Insiders Are Dumping These 10 Healthcare Stocks
|